Need for a new paradigm for the clinical trials of antidepressants

Neuropsychopharmacology

Volumn 19, Issue 6, 1998, Pages 517-522

  Katz, M M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antidepressants; Behavioral assessment; Clinical trials; Componential model; Diagnostic subtypes

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN MONOAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECT; BEHAVIOR; CLINICAL TRIAL; DEPRESSION; DISEASE CLASSIFICATION; DRUG EFFICACY; METHODOLOGY; PRIORITY JOURNAL; RATING SCALE; REVIEW; SYMPTOM;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS; MODELS, PSYCHOLOGICAL; RESEARCH DESIGN;

EID: 0031753135     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00065-7     Document Type: Review

References (43)